Mycoplasma in severe asthma - 17/08/11
Editor’s note: This feature, Images in allergy and immunology, is designed to highlight current concepts of the immunopathology of allergic diseases and other common immunologically mediated diseases. The presentation will appear as sets of images that involve cross-pathology, histopathology, and molecular pathology and will cover a range of topics of interest to allergists and immunologists. Disclosure of potential conflict of interest: M. Kraft has consultant arrangements with GlaxoSmithKline, Novartis, and Genentech; has received grants/research support from GlaxoSmithKline, Genentech, and Boehringer Ingelheim; and is on the speaker’s bureau for Sepracor, GlaxoSmithKline, Schering Plough, Genentech, Novartis, Merck, and AstraZeneca. Q. Hamid has declared that he has no conflict of interest. |
Vol 117 - N° 5
P. 1197-1198 - mai 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?